<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Othaim AA</submitter><funding>Prince Sattam bin Abdulaziz University</funding><pagination>1263</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11510541</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(10)</volume><pubmed_abstract>&lt;h4>Background/objectives&lt;/h4>&lt;i>PRKACA&lt;/i> alterations have clear diagnostic and biological roles in the fibrolamellar variant of hepatocellular carcinoma and a potential predictive role in that cancer type. However, the roles of &lt;i>PRKACA&lt;/i> have not been comprehensively examined in gastric and colorectal cancers (GC and CRC). This study, therefore, sought to investigate the roles of &lt;i>PRKACA&lt;/i> expression in GC and CRC.&lt;h4>Methods&lt;/h4>The clinico-genomic data of 441 GC and 629 CRC cases were analyzed for therapeutic, clinicopathological, and biological correlates using appropriate bioinformatics and statistical tools. Furthermore, the deregulation of &lt;i>PRKACA&lt;/i> expression in GC and CRC was investigated using correlative and regression analyses.&lt;h4>Results&lt;/h4>The results showed th</pubmed_abstract><journal>Pharmaceuticals (Basel, Switzerland)</journal><pubmed_title>Therapeutic, Clinicopathological, and Molecular Correlates of &lt;i>PRKACA&lt;/i> Expression in Gastrointestinal Cancers.</pubmed_title><pmcid>PMC11510541</pmcid><funding_grant_id>PSAU/2023/R/1445</funding_grant_id><pubmed_authors>Othaim AA</pubmed_authors><pubmed_authors>Alfahed A</pubmed_authors><pubmed_authors>Alasiri G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Therapeutic, Clinicopathological, and Molecular Correlates of &lt;i>PRKACA&lt;/i> Expression in Gastrointestinal Cancers.</name><description>&lt;h4>Background/objectives&lt;/h4>&lt;i>PRKACA&lt;/i> alterations have clear diagnostic and biological roles in the fibrolamellar variant of hepatocellular carcinoma and a potential predictive role in that cancer type. However, the roles of &lt;i>PRKACA&lt;/i> have not been comprehensively examined in gastric and colorectal cancers (GC and CRC). This study, therefore, sought to investigate the roles of &lt;i>PRKACA&lt;/i> expression in GC and CRC.&lt;h4>Methods&lt;/h4>The clinico-genomic data of 441 GC and 629 CRC cases were analyzed for therapeutic, clinicopathological, and biological correlates using appropriate bioinformatics and statistical tools. Furthermore, the deregulation of &lt;i>PRKACA&lt;/i> expression in GC and CRC was investigated using correlative and regression analyses.&lt;h4>Results&lt;/h4>The results showed th</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Sep</publication><modification>2026-04-08T19:26:09.834Z</modification><creation>2025-04-19T17:26:06.363Z</creation></dates><accession>S-EPMC11510541</accession><cross_references><pubmed>39458904</pubmed><doi>10.3390/ph17101263</doi></cross_references></HashMap>